Peer-Reviewed Publications

      Development of models for the estimation of mouth level exposure to aerosol constituents from a heat-not-burn tobacco product using mouthpiece analysis

      Poget, L.; Campelos, P. B.; Jeannet, C.; Maeder, S.

      Published
      Feb 10, 2017
      DOI
      10.1515/cttr-2017-0005
      Link to publication
      Topic
      Summary

      Philip Morris International has developed a heat-not-burn tobacco heating system (THS 2.2) that produces an aerosol without combustion. Adult smokers are anticipated to use the product with differing behaviors, such as puffing volume or puffing frequency, therefore it was important to find an easy way to study how users are exposed to the aerosol constituents. Thus, the intended outcome of this study was to propose and assess a simple approach for the estimation of THS users’ exposure to harmful and potentially harmful constituents (HPHCs). THS operates using tobacco sticks (HeatSticks) that include a mouthpiece and a tobacco plug which, when heated, generates an aerosol. The analysis of nicotine retained in the mouthpiece of the HeatSticks during use was identified as a potential approach to estimate users’ mouth level exposure (MLE) to HPHCs. Consequently, the following study was conducted with the objectives 1.) to assess the correlation between the quantity of retained nicotine in the mouthpiece (Nicotine MP) of the HeatSticks and the nicotine delivered in the aerosol of machine-smoked products, 2.) to verify the practical range for Nicotine MP based on the analysis of used HeatSticks left by THS users, and 3.) to develop models describing the relationship between Nicotine MP and specific aerosol constituents measured in the aerosol of machine-smoked products. The regular non-mentholated HeatSticks variant was machine-smoked under various smoking regimens to cover the range of anticipated human puffing behaviors. The suitability of this practical range of machine-smoking conditions was verified by collecting used HeatSticks from two different trials conducted with THS users. The determined Nicotine MP distribution indicated that the machine-smoked regimens encompassed the range observed for users. Multiple Linear Regression (MLR) combined with a stepwise approach was used for selecting models describing the relationship between Nicotine MP and specific aerosol constituents. The stepwise approach interactively explores which amongst various tested predictors provides a good fit. The developed models showed good adjusted coefficients of determination (i.e., R2 adj. ≥ 0.75) for 28 out of the 43 investigated HPHCs. Previously published studies showed that actual MLE can be estimated from cigarette filter analysis. This study demonstrated that the analysis of nicotine in THS mouthpiece (filter section) corresponded to an estimation of the upper limits of MLE, in line with maximum possible usage conditions.

      Related Publications

      Indoor Air Chemistry - An exploratory study on e-cigarette shows no negative impact on indoor air quality

      Aerosol Chemistry

      Indoor air chemistry - An exploratory study on e-cigarette shows no negative impact on indoor air quality

      Aerosol Chemistry

      Computer-Assisted Structure Identification (CASI) for high-throughput identification of small molecules using GC×GC-HRAM-TOFMS high-resolution accurate mass spectrometry

      Aerosol Chemistry

      Computer-Assisted Structure Identification (CASI) for high-throughput identification of small molecules using GC×GC-HRAM-TOFMS high-resolution accurate mass spectrometry

      Aerosol Chemistry

      Air quality assessment during indoor use of the Tobacco Heating System 2.2

      Aerosol Chemistry

      Air quality assessment during indoor use of the Tobacco Heating System THS 2.2

      Aerosol Chemistry

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.